RBP4 and obesity due to melanocortin 4 receptor deficiency: However, FEN has also been shown to reduce obesity and hyperleptinaemia in mice lacking RBP4, implying that the anti-obesity effects of FEN are most likely to be independent of its ability to decrease circulating RBP4 levels [16].